These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 21237521

  • 21. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF, Gao J, Zhang D, Wang ZH, Zhu JY.
    Chin Med J (Engl); 2010 Apr 05; 123(7):942-8. PubMed ID: 20497692
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T, Emmelot ME, Verdonck LF, Mutis T.
    Eur J Immunol; 2008 May 05; 38(5):1381-90. PubMed ID: 18412171
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S, Jiang J, Guan Q, Lan Z, Wang H, Nguan CY, Jevnikar AM, Du C.
    Transpl Immunol; 2008 May 05; 19(2):93-102. PubMed ID: 18503884
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A, Noble A.
    J Leukoc Biol; 2007 Nov 05; 82(5):1053-61. PubMed ID: 17684039
    [Abstract] [Full Text] [Related]

  • 36. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y.
    Transpl Immunol; 2007 Apr 05; 17(3):153-61. PubMed ID: 17331841
    [Abstract] [Full Text] [Related]

  • 37. Structural aspects of the FOXP3 regulatory complex as an immunopharmacological target.
    Zhou Z, Song X, Berezov A, Li B, Greene MI.
    Int Immunopharmacol; 2009 May 05; 9(5):518-20. PubMed ID: 19539569
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Development and maintenance of regulatory T cells.
    Ohkura N, Kitagawa Y, Sakaguchi S.
    Immunity; 2013 Mar 21; 38(3):414-23. PubMed ID: 23521883
    [Abstract] [Full Text] [Related]

  • 40. Transcriptional regulation of Foxp3 in regulatory T cells.
    Haiqi H, Yong Z, Yi L.
    Immunobiology; 2011 Jun 21; 216(6):678-85. PubMed ID: 21122941
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.